by The urea breath test (UBT) is a non-invasive breath test used to detect the presence of the bacterium Helicobacter pylori (H. pylori) in the stomach and duodenum. UBT provides fast and accurate diagnosis of H. pylori infection without the need for invasive endoscopy. The test involves ingesting a capsule or liquid containing isotope-labeled urea followed by exhaled breath samples that are analyzed for the presence of radioactive carbon dioxide, which would indicate the presence of H. pylori. UBT offers advantages over traditional invasive endoscopy or stool antigen tests as it provides rapid results within minutes and is more comfortable for patients.
The Global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031.
Key Takeaways
Key players: Key players in the market such as Al Dahra, ACX Global Inc. and Alfalfa Monegros SL are focusing on expanding their product portfolio and geographical presence to leverage lucrative growth opportunities.
Growing demand: There is growing demand for Urea Breath Test Market Share due to increasing prevalence of H. pylori infections globally and rapid shift towards non-invasive diagnostic procedures.
Global expansion: Major players are expanding their global footprint through strategic acquisitions and partnerships to consolidate their market share in high potential geographical regions.
Market key trends
One of the key trends gaining momentum in the urea breath test market is the development and commercialization of easy-to-use and portable UBT devices. This is enabling the test to be performed conveniently in physician offices and clinics without the need for specialized laboratories. For instance, companies such as Exalenz Bioscience have launched portable breath testing devices for point-of-care UBT. Furthermore, with growing focus on early-stage disease detection, manufacturers are investing in the development of highly sensitive UBT kits capable of identifying incomplete eradication of H. pylori after initial treatment.
Porter’s Analysis
Threat of new entrants: Low capital requirements and availability of suppliers restrict the threat to some extent.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to differentiated products.
Threat of new substitutes: Substitutes like hydrogen breath test pose moderate threat to the urea breath test market.
Competitive rivalry: The market is highly fragmented with presence of multiple local and international players.
Geographical Regions
North America dominates the global urea breath test market in terms value. High prevalence of Helicobacter pylori infections and presence of key market players drive the market growth in the region. Asia Pacific exhibits the fastest growth during the forecast period. Rising healthcare expenditure, increasing disposable income, and growing awareness regarding urea breath test are factors supporting the market expansion in Asia Pacific.
Europe holds the second largest share in the global urea breath test market. Favorable reimbursement policies and government support for innovative diagnosis and treatment boost the market growth. Latin America and Middle East & Africa are emerging markets projected to offer lucrative opportunities over the next few years.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it.
